Denver, Colorado (www.247marketnews.com) – As traders head into the final stretch of today's session, investor attention remains focused on a diverse group of emerging growth companies.
Download the 24/7 Market News App here https://app.247mnn.com/ or on the App Store
Biotech Spotlight: Tango Therapeutics Delivers One of the Most Impressive Pancreatic Cancer Data Sets of the Year
Tango Therapeutics (NASDAQ:TNGX) surged into the biotech spotlight after reporting highly encouraging early clinical results from its ongoing Phase 1/2 study evaluating vopimetostat in combination with Revolution Medicines' RAS(ON) inhibitor daraxonrasib in patients with MTAP-deleted, RAS-mutant pancreatic cancer.
The data immediately captured investor attention, with the combination producing a remarkable 92% objective response rate among evaluable pancreatic cancer patients, alongside a 90% six-month progression-free survival rate and a 100% disease control rate. In metastatic pancreatic ductal adenocarcinoma, one of the most difficult cancers to treat successfully, results of this magnitude are rare and have positioned Tango as one of the most closely watched oncology stories in the market.
Equally important, the responses appear durable. Median progression-free survival has not yet been reached, indicating that many patients continue to benefit from treatment. The safety profile also remains encouraging, with no treatment-related Grade 4 or Grade 5 adverse events reported and no discontinuations linked to adverse effects.
The strength of these findings has accelerated Tango's plans to advance into Phase 3 development in first-line MTAP-deleted pancreatic cancer. Investors will now be closely monitoring upcoming clinical updates involving vopimetostat in lung cancer and initial TNG456 glioblastoma data expected later this year, both of which could serve as additional value-driving catalysts.
NeOnc Technologies Emerging as a CNS Oncology Story to Watch
NeOnc Technologies (NASDAQ:NTHI) continues gaining visibility among investors seeking exposure to next-generation cancer therapies targeting the central nervous system. The company is focused on glioblastoma and other aggressive brain cancers where treatment options remain limited and survival outcomes continue to challenge physicians and patients alike.
The company's lead programs, NEO100 and NEO212, are designed to address critical unmet needs in neuro-oncology. Given the enormous commercial opportunity associated with successful glioblastoma therapies, investors remain highly attentive to clinical progress and development milestones.
Additional investor interest has been fueled by increased analyst coverage and notable insider buying activity. Chief Executive Officer Amir Heshmatpour has reportedly accumulated more than $500,000 in company stock purchases in recent weeks, while institutional ownership has expanded through firms including Bank of America, State Street Corp, and Barclays. Market participants often monitor these developments closely as indicators of growing confidence in a company's long-term outlook.
American Battery Technology Company Scores Major DOE Victory
American Battery Technology Company (NASDAQ:ABAT) delivered one of today's more important clean-energy developments after successfully overturning a prior Department of Energy grant termination and securing full reinstatement of funding for its commercial-scale lithium refinery initiative.
The restored grant supports a project valued at approximately $115 million and advances development of the company's Tonopah Flats Lithium Project, one of the largest known lithium resources in the United States. Notably, the Department of Energy reinstated funding without reducing the award size or altering major project milestones.
As domestic supply chain security becomes increasingly important to U.S. battery manufacturing and electric vehicle production, ABAT's success strengthens its position within the growing critical minerals sector and provides investors with a significant long-term strategic development to evaluate.
Optical Cable Corporation Returns to Profitability
Optical Cable Corporation (NASDAQ:OCC) delivered a strong earnings performance, reporting a 26.6% increase in revenue and a return to profitability during its second fiscal quarter of 2026.
Revenue climbed to approximately $22.2 million while gross profit expanded more than 42% year-over-year. The company also reported approximately $1.1 million in net income, representing a significant turnaround from prior-year losses.
Perhaps most encouraging was the company's growing backlog, which reached approximately $13.3 million. With continued investment in AI infrastructure, cloud computing, enterprise networking, and data centers worldwide, OCC appears well-positioned to benefit from the ongoing expansion of digital infrastructure spending.
Hong Kong Momentum Returns: Inno Holdings Joins the Rebound Story
Inno Holdings (NASDAQ:INHD) is participating in today's Hong Kong-related meme theme Shares have attracted attention following the company's announcement of a $3 million Development Services Agreement to build an AI-powered used mobile phone sales agent platform. However, INHD trading was halted temporarily.
The initiative reflects growing efforts to integrate artificial intelligence directly into commerce and customer acquisition functions. The planned platform will incorporate AI-driven sales automation, product recommendation capabilities, customer acquisition tools, and analytics systems designed to improve transaction efficiency and scalability. Investors continue watching AI-adoption stories closely, and INHD's announcement places it squarely within one of the market's most active themes.
Texxon and Park Ha Biological Tech
Texxon (NASDAQ:NPT) and Park Ha Biological Tech (NASDAQ:BYAH) are some of today's other intriguing stories emerging from the Hong Kong and China-related trading arena,
Galaxy Digital Holdings
Few sectors have captured investor imagination in 2026 like digital assets, and Galaxy Digital (NASDAQ:GLXY) remains one of the most recognizable institutional crypto platforms operating in public markets. As Bitcoin and broader cryptocurrency markets continue attracting institutional participation, Galaxy's diversified business model spanning asset management, trading, staking, and digital infrastructure places it squarely at the center of the digital asset ecosystem.
The company's growing exposure to artificial intelligence infrastructure and data center opportunities has added another layer to its investment narrative. Investors increasingly view Galaxy not simply as a crypto company but as a broader digital infrastructure platform positioned to benefit from multiple high-growth technology trends simultaneously. Continued strength in cryptocurrency markets could keep Galaxy among the most closely watched names heading into after-hours trading.
Zevra Therapeutics
Rare disease biotechnology companies continue attracting investor interest due to their ability to generate meaningful value from highly targeted therapeutic programs, and Zevra Therapeutics (NASDAQ:ZVRA) remains one of the more closely followed names in the space. The company continues advancing treatments focused on underserved patient populations where significant unmet medical needs remain.
Investors often gravitate toward rare disease developers because successful regulatory milestones can create substantial commercial opportunities despite relatively small patient populations. As healthcare investors position for upcoming clinical and regulatory developments across the biotech sector, Zevra remains firmly on the radar as a company with multiple potential catalysts ahead.
Ascent Solar Technologies
Renewable energy speculation has returned to portions of the market, bringing renewed attention to Ascent Technologies (NASDAQ:ASTI) and its proprietary thin-film solar technology platform. Unlike conventional solar manufacturers, Ascent focuses on lightweight, flexible solar applications that can serve specialized commercial, aerospace, defense, and industrial markets.
The company's unique technology differentiates it from many traditional solar competitors and gives investors exposure to emerging applications where lightweight energy generation solutions may play an increasingly important role. With energy security, defense applications, and advanced manufacturing remaining key themes globally, Ascent Solar continues attracting interest among traders looking for alternative clean-energy opportunities.
Power Hour Takeaway
As the closing bell approaches, traders continue gravitating toward companies tied to some of the market's most powerful themes: artificial intelligence, biotech innovation, digital assets, renewable energy, critical minerals, and global growth opportunities.
Download the 24/7 Market News App here https://app.247mnn.com/ or on the App Store.
Sources and Links
· Galaxy Digital: https://www.galaxy.com
· Zevra Therapeutics: https://www.zevra.com
· Ascent Solar Technologies: https://www.ascentsolar.com
· Tango Therapeutics: https://www.tangotx.com
· NeOnc Technologies: https://www.neonc.com
· Inno Holdings: https://www.innoholdingsinc.com
· American Battery Technology Company: https://www.americanbatterytechnology.com
· Optical Cable Corporation: https://www.occfiber.com
About 24/7 Market News
In today's fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you're an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact [email protected] to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.
This is a paid editorial communication intended for informational purposes only. 24/7 is compensated by NTHI to provide ongoing news coverage of expected upcoming catalysts and events as well as market outreach services. This should not be construed as financial or investment advice. Trading involves substantial risk; consult your financial advisor. For the full disclosure, please visit: https://go.247marketnews.com/nthi-disclosure/
For further information, please visit 247marketnews.com.
CONTACT:
24/7 Market News
[email protected]
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.